Plain-English translation of NCT06335043 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is exploring whether pharmacogenetic testing—a simple genetic test that shows how your body processes different medications—can help your doctor choose mental health medications that work better for you. Researchers will compare two groups: veterans who receive this genetic test to guide their medication choices, and those who receive standard treatment without the test. The goal is to see if personalized medication selection based on your genes can reduce symptoms and side effects more effectively.
Many people with PTSD and related conditions have to try several different medications before finding one that works well with manageable side effects. This genetic test could help doctors predict which medications are most likely to be effective and safe for you specifically, potentially speeding up the path to feeling better.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll complete a short survey about your thoughts on genetic testing. You can then choose whether or not to have the genetic test done. If you opt in, your doctor will receive a report about your genetic results to help guide medication decisions. Either way, the research team will track your PTSD, depression, and anxiety symptoms, as well as any medication side effects, for up to 24 weeks or until you leave the clinic—whichever comes first. You'll also be asked to complete a brief exit interview at the end.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Canada